Analytical Standards Market Report 2026

The analytical standards market size has grown strongly in recent years. It will grow from $1.77 billion in 2025 to $1.9 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to expansion of pharmaceutical and life science testing, growth of food safety and quality testing, increasing environmental monitoring activities, rising forensic analysis requirements, availability of standardized testing protocols.

The analytical standards market size is expected to see strong growth in the next few years. It will grow to $2.49 billion in 2030 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to increasing regulatory scrutiny across industries, rising adoption of advanced analytical instruments, expansion of biologics and complex drug development, growing demand for method validation standards, increasing focus on global harmonization of testing. Major trends in the forecast period include increasing demand for high-purity reference materials, rising adoption of certified analytical standards, growing use in multi-technique testing, expansion of application-specific standards, enhanced focus on traceability and compliance.

The rising demand for new pharmaceutical drugs and therapies is expected to drive the growth of the analytical standards market. Pharmaceutical drugs and therapies are designed to treat, manage, or improve various health conditions, and their demand is increasing due to the growing prevalence of chronic diseases requiring ongoing treatment. Analytical standards are used to ensure accurate testing, quality control, and consistency in medicinal products. For example, in December 2024, the Association of the British Pharmaceutical Industry (ABPI) reported that clinical trials initiated in the UK increased from 411 in 2022 to 426 in 2023. Therefore, the growing need for new pharmaceutical drugs and therapies is propelling the analytical standards market.

Key companies in the analytical standards market are focusing on advancements in endotoxin testing, such as rapid and sensitive monocyte activation tests (MAT), to improve efficiency, accuracy, and regulatory compliance in pharmaceutical and medical device safety testing. MAT assays detect pyrogens, including bacterial endotoxins, by measuring monocyte activation. For instance, in June 2024, FUJIFILM Wako Chemicals, a US-based manufacturer of chemical reagents, launched the LumiMAT Pyrogen Detection Kit, a rapid, sensitive in vitro assay using human NOMO-1 cells, and PYROSTAR Neo+, a recombinant protein reagent for detecting bacterial endotoxins with enhanced sensitivity and reduced drug interference. These products offer faster and more reliable alternatives to traditional testing methods.

In May 2023, Waters Corporation, a US-based analytical instrument manufacturer, acquired Wyatt Technology for $1.36 billion. This acquisition enables Waters to expand its analytical instrument portfolio and enhance capabilities in bioanalytical characterization and large-molecule analysis, supporting growing demand in pharmaceuticals, biologics, and advanced research markets. Wyatt Technology, based in the US, specializes in analytical standards, including BSA solutions, Dextran standards, and polystyrene standards.

Major companies operating in the analytical standards market are LGC Standards, USP (United States Pharmacopeia), AccuStandard Inc., Restek Corporation, Chiron AS, Toronto Research Chemicals, Cayman Chemical Company, Wellington Laboratories, SPEX CertiPrep, ERA (Environmental Resource Associates), NSI Lab Solutions, Cambridge Isotope Laboratories, Absolute Standards, PhytoLab GmbH & Co. KG, Greyhound Chromatography, GFS Chemicals, Inorganic Ventures, High-Purity Standards, UL Solutions, Reagecon Diagnostics.

North America was the largest region in the analytical standards market in 2025. Asia-Pacific is expected to be the fastest-growing region in the market. The regions covered in the analytical standards market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the analytical standards market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The analytical standards market consists of revenues earned by entities by providing primary and secondary analytical standards. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.